GB949684A - Process for inactivating poliomyelitis virus - Google Patents
Process for inactivating poliomyelitis virusInfo
- Publication number
- GB949684A GB949684A GB43811/60A GB4381160A GB949684A GB 949684 A GB949684 A GB 949684A GB 43811/60 A GB43811/60 A GB 43811/60A GB 4381160 A GB4381160 A GB 4381160A GB 949684 A GB949684 A GB 949684A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acid
- inactivating
- chelate
- virus
- poliomyelitis virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000700605 Viruses Species 0.000 title abstract 4
- 208000000474 Poliomyelitis Diseases 0.000 title abstract 2
- 230000000415 inactivating effect Effects 0.000 title abstract 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 3
- 239000013522 chelant Substances 0.000 abstract 3
- RNMCCPMYXUKHAZ-UHFFFAOYSA-N 2-[3,3-diamino-1,2,2-tris(carboxymethyl)cyclohexyl]acetic acid Chemical compound NC1(N)CCCC(CC(O)=O)(CC(O)=O)C1(CC(O)=O)CC(O)=O RNMCCPMYXUKHAZ-UHFFFAOYSA-N 0.000 abstract 1
- QDHGQJQZPJPKJK-UHFFFAOYSA-N 2-[carboxymethyl-(2,4,6-trioxo-1,3-diazinan-5-yl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)C1C(=O)NC(=O)NC1=O QDHGQJQZPJPKJK-UHFFFAOYSA-N 0.000 abstract 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N Acetoacetic acid Natural products CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 abstract 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 abstract 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
- 239000005977 Ethylene Substances 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 102000004407 Lactalbumin Human genes 0.000 abstract 1
- 108090000942 Lactalbumin Proteins 0.000 abstract 1
- -1 acetoacetic acid ester Chemical class 0.000 abstract 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 abstract 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000000413 hydrolysate Substances 0.000 abstract 1
- 230000002779 inactivation Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32661—Methods of inactivation or attenuation
- C12N2770/32663—Methods of inactivation or attenuation by chemical treatment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEB55993A DE1131846B (de) | 1959-12-22 | 1959-12-22 | Verfahren zur Inaktivierung von Poliomyelitisviren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB949684A true GB949684A (en) | 1964-02-19 |
Family
ID=6971173
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB43811/60A Expired GB949684A (en) | 1959-12-22 | 1960-12-20 | Process for inactivating poliomyelitis virus |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE598471A (hr) |
| CH (1) | CH399653A (hr) |
| DE (1) | DE1131846B (hr) |
| FR (1) | FR1023M (hr) |
| GB (1) | GB949684A (hr) |
| SE (1) | SE309826B (hr) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1042179B (de) * | 1957-07-11 | 1958-10-30 | Pasteur Institut | Verfahren zur Herstellung antigenhaltiger Impfstoffe |
-
1959
- 1959-12-22 DE DEB55993A patent/DE1131846B/de active Pending
-
1960
- 1960-12-16 CH CH1412560A patent/CH399653A/de unknown
- 1960-12-20 GB GB43811/60A patent/GB949684A/en not_active Expired
- 1960-12-22 BE BE598471A patent/BE598471A/fr unknown
- 1960-12-22 SE SE12424/60A patent/SE309826B/xx unknown
-
1961
- 1961-03-21 FR FR856343A patent/FR1023M/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BE598471A (fr) | 1961-06-22 |
| SE309826B (hr) | 1969-04-08 |
| FR1023M (hr) | 1961-12-26 |
| DE1131846B (de) | 1962-06-20 |
| CH399653A (de) | 1965-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK534288D0 (da) | Hidtil ukendt proces | |
| IE35642B1 (en) | A process for the preparation of new alpha-aminopenicillins and such penicillins and intermediates and pharmaceutical preparations | |
| DE3872137D1 (de) | Verfahren zur herstellung eines hochreinen, virussicheren, biologisch aktiven transferrinpraeparates. | |
| GB949684A (en) | Process for inactivating poliomyelitis virus | |
| ES443052A1 (es) | Procedimiento para la preparacion de un derivado de la cade-na ligera de la toxina tetanica. | |
| SE7500130L (hr) | ||
| GB723547A (en) | Esters and nitriles of alphahaloacrylic acids | |
| GB1442564A (en) | Process for preparing inactivated hb ag vaccine | |
| GB913519A (en) | Process for the production of stable non-heat coagulable protein preparations | |
| GB806949A (en) | Production of pharmaceutical preparations | |
| GB894623A (en) | Process for cultivating the virus of foot-and-mouth disease | |
| GB1089765A (en) | Purification of polymyxin | |
| GB1019073A (en) | Process for preparing an antipoliomyelitis vaccine | |
| GB1492441A (en) | Confirming a desired heat effect on a material | |
| GB844979A (en) | A method for increasing the water-soluble portion of animal muscle protein and obtaining muscle protein extracts | |
| KR790000120B1 (en) | Process for preparing cyclopropane derivatives | |
| SU70583A1 (ru) | Способ лечени микробных инфекций | |
| GB919530A (en) | A process for the production of an amino acid complex | |
| GB770852A (en) | Vaccine products and process of producing the same | |
| GB922027A (en) | Poliomyelitis vaccine production | |
| ES345550A1 (es) | Procedimiento para la preparacion de un glocopeptido. | |
| GB477232A (en) | Improvements in or relating to methods of treating latex | |
| SU367140A1 (ru) | Способ получения автолизата дрожжей | |
| GB1206646A (en) | Improvements in sterilising articles | |
| GB1027036A (en) | Despeciated interferon |